These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36569871)

  • 41. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
    Liu R; Hu Y; Liu T; Wang Y
    BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of 6 gene markers for survival prediction in osteosarcoma cases based on multi-omics analysis.
    Li R; Wang G; Wu Z; Lu H; Li G; Sun Q; Cai M
    Exp Biol Med (Maywood); 2021 Jul; 246(13):1512-1523. PubMed ID: 33563042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Osteosarcoma subtypes based on platelet-related genes and tumor microenvironment characteristics.
    Shu Y; Peng J; Feng Z; Hu K; Li T; Zhu P; Cheng T; Hao L
    Front Oncol; 2022; 12():941724. PubMed ID: 36212395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma.
    Zhou Y; Li G; Li H; Lai F; Duan P; Cheng M
    J Immunol Res; 2022; 2022():1377565. PubMed ID: 35836470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune-based prognostic biomarkers associated with metastasis of osteosarcoma.
    Ma T; Peng C; Wu D; Yang S; Ji L; Cheng Z; Gao C
    Gen Physiol Biophys; 2023 Jan; 42(1):1-12. PubMed ID: 36705300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma.
    Wang Q; Zhang W; Guo Y; Li Y; Fu K
    Aging (Albany NY); 2021 Nov; 13(21):24155-24170. PubMed ID: 34747719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
    Wu ZY; Shi ZY
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing.
    Song P; Li W; Guo L; Ying J; Gao S; He J
    Front Immunol; 2022; 13():850745. PubMed ID: 35757748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer.
    Zhang W; Liu T; Jiang L; Chen J; Li Q; Wang J
    Front Genet; 2022; 13():1001239. PubMed ID: 36425071
    [No Abstract]   [Full Text] [Related]  

  • 51. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
    Guo J; Li X; Shen S; Wu X
    Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 53. Molecular subtypes of osteosarcoma classified by cancer stem cell related genes define immunological cell infiltration and patient survival.
    Guo L; Yan T; Guo W; Niu J; Wang W; Ren T; Huang Y; Xu J; Wang B
    Front Immunol; 2022; 13():986785. PubMed ID: 36059448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma.
    Chen J; Guo X; Zeng G; Liu J; Zhao B
    Comput Math Methods Med; 2020; 2020():8081973. PubMed ID: 33082842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Construction and validation model of necroptosis-related gene signature associates with immunity for osteosarcoma patients.
    Hua L; Lei P; Hu Y
    Sci Rep; 2022 Sep; 12(1):15893. PubMed ID: 36151259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune Infiltration.
    Fu Y; He G; Liu Z; Wang J; Zhang Z; Bao Q; Wen J; Jin Z; Zhang W
    J Inflamm Res; 2021; 14():6719-6734. PubMed ID: 34916821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
    Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
    Front Immunol; 2022; 13():943389. PubMed ID: 36003381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioinformatics analysis of the key genes in osteosarcoma metastasis and immune invasion.
    Liang J; Chen J; Hua S; Qin Z; Lu J; Lan C
    Transl Pediatr; 2022 Oct; 11(10):1656-1670. PubMed ID: 36345453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma.
    Xiao B; Liu L; Li A; Xiang C; Wang P; Li H; Xiao T
    Front Oncol; 2020; 10():607622. PubMed ID: 33384961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.